ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,944, issued on Sept. 22, was assigned to University of Virginia Patent Foundation (Charlottesville, Va.) and Virginia Tech Intellectual Properties Inc. (Blacksburg, Va.).
"Inhibitors of spinster homolog 2 (SPNS2) for use in therapy" was invented by Kevin R. Lynch (Charlottesville, Va.), Yugesh Kharel (Charlottesville, Va.), Webster L. Santos (Blacksburg, Va.), Russell G. Fritzemeier (Atlanta), Ariel Louise Burgio (Christiansburg, Va.), Christopher Shrader (Blacksburg, Va.) and Daniel Foster (Blacksburg, Va.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides SPNS2 inhibitor compounds according to Formula (IA) and Formula ...